Bright Minds biosciences receives non-compliance notice from Nasdaq

Feb. 08, 2023 4:55 PM ETBright Minds Biosciences Inc. (DRUG)By: Dania Nadeem, SA News Editor
  • Bright Minds Biosciences (NASDAQ:DRUG) said it had received a letter from the Nasdaq stating that following the resignation of Williamson from the company’s board of directors and audit committee, the Company no longer complies with its independent director and audit committee requirements.
  • The Company has until July 10 to regain compliance.
  • The Company is currently in advanced discussions with a potential new director and anticipates regaining compliance within the Cure Period.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.